Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Dissociation Market
Cell Dissociation Market size was valued to be USD 378.3 million in 2022 and is expected to reach USD 1.6 billion in 2032, growing at a CAGR of 15.3% by 2032 driven by the rising focus on the development of cell-based therapeutics that has led to the development of patient-specific cell therapies.
Cell dissociation is essential for isolating and culturing cells. Also, there is a notable increase in interest and investment in cell-based research. Government, private firms, and biotechnology companies are dedicating substantial resources to support cell therapy technologies in areas such as stem cell biology, regenerative medicine, and immunotherapy. For instance, the U.S. National Institutes of Health (NIH) allocate significant funds around a billion dollars per year to support stem cell research. Additionally, collaborations and partnerships between academia and industry are common, facilitating research translation.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Cell Dissociation Market Size in 2022: | USD 378.3 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 15.3% |
2032 Value Projection: | USD 1.6 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 150 |
Tables, Charts & Figures: | 263 |
Segments covered: | Product, Application, End-user, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Cell dissociation refers to the process of separating and isolating individual cells or cell clusters from a tissue, organ, or cell culture. This process typically involves breaking down cell-to-cell and cell-to-substrate adhesions to release the constituent cells, allowing them to be suspended as individual entities in a solution.